Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 9Strides Pharma Science
02 3Accord healthcare
03 3Actavis Inc
04 3Adcock Ingram
05 1Ajanta Pharma Limited
06 3Alembic Pharmaceuticals Limited
07 1Alvogen
08 4Amneal Pharmaceuticals
09 6Atabay
10 1Aurobindo Pharma Limited
11 2Biofarm
12 1Cipla Medpro South Africa
13 4Epic Pharma. LLC.
14 26F. Hoffmann-La Roche
15 1Farm Agon
16 1Hainan Poly Pharm
17 6Hetero Drugs
18 3Intas Pharmaceuticals
19 4InvaGen Pharmaceuticals Inc
20 2JAMP PHARMA
21 1JV Pharmland
22 1Jivita Health Care
23 1Jubilant Generics
24 3Kolmar Korea Co., Ltd.
25 3Laurus Labs
26 1Leading Pharma, LLC
27 3Lunan Pharmaceutical
28 4Lupin Ltd
29 2MINT PHARMACEUTICALS INC
30 4MSN Laboratories
31 8Macleods Pharmaceuticals Limited
32 4Mahban Group
33 2NANJING DAOQUN
34 3Natco Pharma
35 4Natco Pharma (Canada) Inc
36 3Neolpharma
37 1Nile Pharma
38 2Orbit Lifescience
39 1Oryza Pharmaceuticals
40 3Rising Pharmaceuticals Inc
41 3Sandoz B2B
42 2Smith & Kenner Pharmaceuticals
43 1Strides Pharma SA (Pty) Ltd
44 4Sunshine Lake Pharma
45 4Teva Pharmaceutical Industries
46 1Viatris South Africa (Pty) Ltd
47 4Zydus Pharmaceuticals
01 15CAP
02 16CAPSULE
03 57CAPSULE;ORAL
04 17Capsule
05 4Capsule, hard
06 3Capsules
07 18FOR SUSPENSION;ORAL
08 6HARD CAPSULES
09 3Hard Capsule
10 1Hard Gelatin Capsule
11 1Oral Solution
12 1Oral Suspension
13 2POWDER FOR ORAL SUSPENSION
14 2POWDER FOR SUSPENSION
15 1Powder for Oral Suspension
16 1Powder for potion, suspension
17 2SUS
18 2SYR
19 1Suspension
20 1Tablet
21 1Tablet
22 2Blank
01 8DISCN
02 15Generic
03 3Generic US CTD
04 6Originator
05 67RX
06 58Blank
01 1Cipla Oseltamivir
02 5ENFLUVIR
03 1ENFLUVIR
04 3Ebilfumin
05 1FLUMITEV 30
06 1FLUMITEV 45
07 1FLUMITEV 75
08 2JAMP OSELTAMIVIR
09 2MCOSVIR
10 2MINT-OSELTAMIVIR
11 1Macselta 75 mg Capsules
12 1Mahbaflu 75
13 4NAT-OSELTAMIVIR
14 1OSELTAMIVIR CAPSULE ORAL 30 mg
15 1OSELTAMIVIR CAPSULE ORAL 45 mg
16 1OSELTAMIVIR CAPSULE ORAL 75 mg
17 70OSELTAMIVIR PHOSPHATE
18 1Oselflu
19 3Oseltami Capsule
20 1Oseltamivir Adco 30 mg
21 1Oseltamivir Adco 45 mg
22 1Oseltamivir Adco 75 mg
23 5Oseltamivir Phosphate
24 1Ozetir
25 3SANDOZ OSELTAMIVIR
26 1Selvitran 75mg
27 9TAMIFLU
28 2TAMIVIL
29 1Tamicold
30 14Tamiflu
31 1Tamiflu 30 Mg
32 1Tamiflu 45 Mg
33 2Tamiflu 6mg/ml
34 1Taminil - N
35 1Tamygen
36 1ZAAFLU
37 9Blank
01 1Belarus
02 15Canada
03 1Egypt
04 13India
05 4Iran
06 2Italy
07 5Norway
08 2Poland
09 19South Africa
10 3South Korea
11 8Sweden
12 6Turkey
13 75USA
14 3United Kingdom
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 2018-06-08
Application Number : 209421
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 45MG BASE
Packaging :
Approval Date : 2018-06-08
Application Number : 209421
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2018-06-08
Application Number : 209421
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 6MG BASE/ML
Packaging :
Approval Date : 2022-01-13
Application Number : 211894
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Oseltamivir Phosphate
Dosage Form : Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Oseltamivir Phosphate
Dosage Form : Capsule
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Oseltamivir Phosphate
Dosage Form : Capsule
Dosage Strength : 45MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Oseltamivir Phosphate
Dosage Form : Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Oseltamivir Phosphate
Dosage Form : Oral Solution
Dosage Strength : 6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : TAMIFLU
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 1999-10-27
Application Number : 21087
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TAMIFLU
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 45MG BASE
Packaging :
Approval Date : 2007-07-02
Application Number : 21087
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TAMIFLU
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 2007-07-02
Application Number : 21087
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TAMIFLU
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 12MG BASE/ML
Packaging :
Approval Date : 2000-12-14
Application Number : 21246
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TAMIFLU
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 6MG BASE/ML
Packaging :
Approval Date : 2011-03-21
Application Number : 21246
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 2017-09-14
Application Number : 207211
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 45MG BASE
Packaging :
Approval Date : 2017-09-14
Application Number : 207211
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2017-09-14
Application Number : 207211
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 2016-08-03
Application Number : 202595
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 45MG BASE
Packaging :
Approval Date : 2016-08-03
Application Number : 202595
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OSELTAMIVIR PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2016-08-03
Application Number : 202595
Regulatory Info : RX
Registration Country : USA
